Schittek, B <br/><br/>
Amplification of MelanA messenger RNA in addition to tyrosinase increases sensitivity of melanoma cell detection in peripheral blood and is associated with the clinical stage and prognosis of malignant melanoma.  [electronic resource] 

 -  The British journal of dermatology  Jul 1999 
 - 30-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-0963 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2133.1999.02917.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antigens, Neoplasm<br/>Chi-Square Distribution<br/>Female<br/>Humans<br/>MART-1 Antigen<br/>Male<br/>Melanoma--blood<br/>Middle Aged<br/>Monophenol Monooxygenase--genetics<br/>Neoplasm Proteins--genetics<br/>Neoplastic Cells, Circulating<br/>Prognosis<br/>RNA, Messenger--blood<br/>Reverse Transcriptase Polymerase Chain Reaction--methods<br/>Sensitivity and Specificity<br/>Skin Neoplasms--blood